Literature DB >> 9178240

Dynamic liver imaging with iron oxide agents: effects of size and biodistribution on contrast.

J B Mandeville1, J Moore, D A Chesler, L Garrido, R Weissleder, R M Weisskoff.   

Abstract

In vivo effective relaxation rates in normal rat liver were evaluated for four dextran coated iron oxide agents: monocrystalline iron oxide nanocolloid (MION) with a mean particle diameter of 3.9 nm, a polycrystalline agent (PION) with a larger mean diameter of 12 nm, and these two agents labeled with the asialofetuin (ASF) protein for high hepatocytic receptor binding affinity (MION-ASF and PION-ASF). Using echo planar imaging at 2 Tesla, dose response was measured with measured with high temporal resolution for 3 h after injection of agent, and by comparing with relaxivities in vitro and in brain, dominant in vivo contrast phenomena were elucidated. While transverse relaxivity for PION-ASF exceeded that for MION-ASF by almost a factor of 2 in solution, relaxation rates in vivo became equivalent. Liver relaxation using non-ASF agents was consistent with rapid water exchange between vascular and extravascular compartments, which dominated relaxation as a result of agent accumulation in Kupffer cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9178240     DOI: 10.1002/mrm.1910370613

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  8 in total

Review 1.  Rational chemical design of the next generation of molecular imaging probes based on physics and biology: mixing modalities, colors and signals.

Authors:  Hisataka Kobayashi; Michelle R Longmire; Mikako Ogawa; Peter L Choyke
Journal:  Chem Soc Rev       Date:  2011-05-23       Impact factor: 54.564

2.  Simulating Magnetic Nanoparticle Behavior in Low-field MRI under Transverse Rotating Fields and Imposed Fluid Flow.

Authors:  P Cantillon-Murphy; L L Wald; E Adalsteinsson; M Zahn
Journal:  J Magn Magn Mater       Date:  2010-09       Impact factor: 2.993

3.  'NC100150', a preparation of iron oxide nanoparticles ideal for positive-contrast MR angiography.

Authors:  K E Kellar; D K Fujii; W H Gunther; K Briley-Saebø; M Spiller; S H Koenig
Journal:  MAGMA       Date:  1999-08       Impact factor: 2.310

4.  Pre-clinical results with Clariscan (NC100150 Injection); experience from different disease models.

Authors:  A Bjørnerud; L O Johansson; H K Ahlström
Journal:  MAGMA       Date:  2001-05       Impact factor: 2.310

5.  Reduced microvascular volume and hemispherically deficient vasoreactivity to hypercapnia in acute ischemia: MRI study using permanent middle cerebral artery occlusion rat model.

Authors:  J Y Suh; Woo H Shim; Gyunggoo Cho; Xiang Fan; Seon J Kwon; Jeong K Kim; George Dai; Xiaoying Wang; Young R Kim
Journal:  J Cereb Blood Flow Metab       Date:  2015-02-18       Impact factor: 6.200

Review 6.  Current trends and challenges in MRI acquisitions to investigate brain function.

Authors:  Bradley P Sutton; Cheng Ouyang; Dimitrios C Karampinos; Gregory A Miller
Journal:  Int J Psychophysiol       Date:  2009-02-21       Impact factor: 2.997

7.  Quantification and biodistribution of iron oxide nanoparticles in the primary clearance organs of mice using T1 contrast for heating.

Authors:  Jinjin Zhang; Hattie L Ring; Katie R Hurley; Qi Shao; Cathy S Carlson; Djaudat Idiyatullin; Navid Manuchehrabadi; P Jack Hoopes; Christy L Haynes; John C Bischof; Michael Garwood
Journal:  Magn Reson Med       Date:  2016-09-25       Impact factor: 4.668

8.  In vivo biodistribution of iron oxide nanoparticles: an overview.

Authors:  Jennifer A Tate; Alicia A Petryk; Andrew J Giustini; P Jack Hoopes
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2011-02-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.